Estimates of incidence rates with longitudinal claims data

Archives of Ophthalmology

Volumn 121, Issue 10, 2003, Pages 1462-1468

  Sloan, Frank A ^a   Brown, Derek S ^a   Carlisle, Emily S ^a   Ostermann, Jan ^a   Lee, Paul P ^b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; GLAUCOMA; HEALTH MAINTENANCE ORGANIZATION; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; MEDICARE; OPHTHALMOLOGY; OPTOMETRY; POPULATION RESEARCH; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION;

CHRONIC DISEASE; DIABETIC RETINOPATHY; GLAUCOMA; HEALTH SURVEYS; HUMANS; INCIDENCE; INSURANCE CLAIM REPORTING; MACULAR DEGENERATION; MEDICARE PART A; MEDICARE PART B; UNITED STATES; UNITED STATES CENTERS FOR MEDICARE AND MEDICAID SERVICES;

EID: 0141885205     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.121.10.1462     Document Type: Article

References (28)

1. Klein R, Klein BEK, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1997;104:7-21.
2. Mitchell P, Wang JJ, Foran S, Smith W. Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology. 2002;109:1092-1097.
3. Leske MC, Connell AM, Wu SY, et al. Incidence of open-angle glaucoma: the Barbados Eye Studies: the Barbados Eye Studies Group. Arch Ophthalmol. 2001; 119:89-95.
4. Wu SY, Nemesure B, Leske MC. Observed versus indirect estimates of open-angle glaucoma. Am J Epidemiol. 2001;153:184-187.
5. Klein R, Klein BEK, Moss SC, Davis MD, De Mets DL. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol. 1989;107:244-249.
6. Lee PP, Feldman ZW, Ostermann J, Brown DS, Sloan FA. Longitudinal prevalence of major eye diseases. Arch Ophthalmol. 2003;121:1303-1310.
7. American Academy of Ophthalmology. Preferred Practice Pattern: Diabetic Retinopathy. San Francisco, Calif: American Academy of Ophthalmology; 1998.
8. American Academy of Ophthalmology. Preferred Practice Pattern: Glaucoma. San Francisco, Calif: American Academy of Ophthalmology; 2000.
9. American Academy of Ophthalmology. Preferred Practice Pattern: Age-related Macular Oegeneration, Limited Revision. San Francisco, Calif: American Academy of Ophthalmology; 2001.
10. American Diabetes Association. Diabetic retinopathy. Diabetes Care. 2002;25 (suppl 1):S90-S93. Available at: http://care.diabetesjournals.org/cgi/content/full/25/suppl_1/s90. Accessed September 2, 2003.
11. Nielsen NV. Diabetic retinopathy I: the course of retinopathy in insulin-treated diabetics: a one year epidemiological cohort study of diabetes mellitus: the Island of Falster, Denmark. Acta Ophthalmol (Copenh). 1984;62:256-265.
12. Nielsen NV. Diabetic retinopathy II: the course of retinopathy in diabetics treated with oral hypoglycemic agents and diet regime alone: a one year epidemiological cohort study of diabetes mellitus: the Island of Falster, Denmark. Acta Ophthalmol (Copenh). 1984;62:266-273.
13. Tudor SM, Hamman RF, Baron A, Johnson DW, Shetterly SM. Incidence and progression of diabetic retinopathy in Hispanics and non-Hispanic whites with type 2 diabetes: San Luis Valley Diabetes Study, Colorado. Oiabetes Care. 1998;21:53-61.
14. Pogdor MJ, Leske MC, Ederer F. Incidence estimates for lens changes, macular changes, open-angle glaucoma, and diabetic retinopathy. Am J Epidemiol. 1983; 118:206-212.
15. Lee VS, Kingsley RM, Lee ET, et al. The diagnosis of diabetic retinopathy: ophthalmoscopy versus fundus photography. Ophthalmology. 1993;100:1504-1512.
16. Mukesh BN, McCarty CA, Rait JL, Taylor HR. Five-year incidence of open-angle glaucoma: the Visual Impairment Project. Ophthalmology. 2002;109:1047-1051.
17. Bohn RL, Gurwitz JH, Yeomans SM, et al. Which patients are treated for glaucoma? An observational analysis. J Glaucoma. 2000;9:38-44.
18. Klaver CC, Assink JJ, van Leeuwen R, et al. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci. 2001; 42:2237-2241.
19. Maciejewski ML, Dowd B, Call KT, Feldman R. Comparing mortality and time until death for Medicare HMO and FFS beneficiaries. Health Serv Res. 2001;35:1245-1265.
20. US General Accounting Office. Medicare: Fewer and Lower Cost Beneficiaries With Chronic Conditions Enroll in HMOs: Report to the Chairman, Subcommittee on Health, Committee on Ways and Means, US House of Representatives, August 1997. Available at: http://www.conginst.org/resultsact/PDF/HE97160.PDF. Accessed September 2, 2003.
21. Shaefer E, Reschovsky JD. Are HMO enrollees healthier than others? Results from the community tracking study. Health Aff (Millwood). 2002;21:249-258.
22. Taylor AK, Beauregard KM, Vistnes JP. Who belongs to HMOs: a comparison of fee-for-service versus HMO enrollees. MCRR. 1995;52:389-408.
23. McFarland BH, Freeborn DK, Mullooly JP, Pope CR. Utilization patterns and mortality of HMO enrollees. Med Care. 1986;24:200-208.
24. Blumberg MS. Health status and health care use by type of private health coverage. Milbank Mem Fund Q Health Soc. 1980;58:633-655.
25. Janz NK, Wren PA, Lichter PR, et al. Quality of life in newly diagnosed glaucoma patients: the Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2001; 108:887-897.
26. US Centers for Disease Control and Prevention. Trends in the prevalence and incidence of self-reported diabetes mellitus-United States, 1980-1994. MMWR Morb Mortal Wkly Rep. 1997;46:1014-1018.
27. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195-1200.
28. Leske MC, Connel AMS, Schachat AP, Hyman L. The Barbados Eye Study: prevalence of open angle glaucoma. Arch Ophthalmol. 1994;112:821-829.